Searchable abstracts of presentations at key conferences in endocrinology

ea0065p147 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Lobectomy for thyroid cancer and thyroglobulin as a tumor marker for long term follow up: current controversies and clarification

Jeeyavudeen Mohammad Sadiq , Graveling Alex , Shakeel Muhammad , Smart Louise , Tasleem Sadia , Aspinall Sebastian , Abraham Prakash

Background: The accuracy of thyroglobulin (Tg) as a tumour marker following lobectomy for differentiated thyroid cancer (DTC) remains controversial. A Tg (<10 µg/l) looked promising in identifying those without clinically apparent recurrence after median 51 months of follow-up. Longer term follow up allows assessment of the diagnostic utility of thyroglobulin in predicting relapse.Methods: Ninety-nine patients who underwent lobectomy for DTC wer...

ea0041ep932 | Pituitary - Clinical | ECE2016

“What’s the best approach to perioperative, immediate post op and 6 week post op cortisol assessment and replacement in patients undergoing transsphenoidal pituitary surgery?”

Tariq Adnan , Bhatt Dhruti , Graveling Alex , Abraham Prakash , Mahmoud Kamel , MacRury Sandra , Bevan John

Introduction: There is great variation in management of perioperative cortisol management in patient’s undergoing pituitary surgery across UK Hospitals. We evaluated safety and effectiveness of standards followed in ARI. The aim of audit was to confirm safety, improve knowledge and change practice for better patient care if needed based on information gained from the available data.Description of methods/design: We evaluated 30 patients who have und...

ea0059p212 | Thyroid | SFEBES2018

Low Dose Radioiodine Therapy for Graves’ disease: comparison of outcomes following administration of different doses across two centres

Sawhney Natasha , Diaz-Ortega Carmen , Philip Sam , Gibb Fraser , Abraham Prakash , Graveling Alex

Introduction: Low dose radioiodine (LDRAI) has been used to treat benign thyroid disease for over 70 years (1). However, controversies remain about the optimal dosage to administer. The Royal College of Physicians guidelines recommend a dosage of 400–600 MBq for uncomplicated Graves’ disease (2); the dose administered varies between centres.Methods: Outcome data at Edinburgh Royal Infirmary were collected retrospectively for patients who receiv...

ea0034p390 | Thyroid | SFEBES2014

Factors contributing to high levothyroxine doses in primary hypothyroidism; an interventional audit of a large community database

Robertson Hannah , Narayanaswamy Anil , Pereira Olivia , Copland Shirley , Herriot Richard , McKinlay Alastair , Bevan John , Abraham Prakash

Background: While few hypothyroid patients require more than the expected weight related dose of levothyroxine, the underlying causes of larger-than-expected dosing requirements have not been studied in a single cohort. Our aim was to determine and quantify the multiple factors contributing to high dose levothyroxine requirements in a cohort of patients with hypothyroidism.Methods: The Grampian Automated Follow-Up Register (GAFUR) monitors around 17 500 ...

ea0028p353 | Thyroid | SFEBES2012

Does quantitative measurement of radioiodine (RAI) uptake on the post-high dose RAI whole body scan (WBS) predict residual disease in thyroid cancer following total thyroidectomy?

McGeoch Susan , Lorimer Lisa , Kumar Radhika , Gemmell Howard , Abraham Prakash , Bevan John

Introduction: In our institution the post high-dose RAI whole body scan (WBS) report includes a measurement of quantitative percentage uptake of the dose of RAI administered although this may not be standard practice elsewhere. We aimed to ascertain whether this was associated with the extent of unresected thyroid tissue or residual thyroid cancer following total thyroidectomy and neck dissection represented by the post-surgery TSH-stimulated thyroglobulin concentrations. Meth...

ea0013p58 | Clinical practice/governance and case reports | SFEBES2007

Extreme pituitary hyperplasia of normal pregnancy presenting as a macroprolactinoma

Acharya Shamasunder , Philip Sam , Danielian Peter , Olson Shona , Bevan John , Abraham Prakash

Case report: A 33-year-old pregnant Nigerian woman presented at 37 wks gestation with a 2-week history of frequent headaches and visual disturbance. She had persistent galactorrhoea following previous pregnancy in 1998, which settled after a short course of bromocriptine. On examination, she had classical bitemporal hemianopia. Her prolactin was raised at 19,220 mU/L (higher than expected in a normal pregnancy), random cortisol 553 nmol/L and thyroid function tests satisfactor...

ea0094p163 | Adrenal and Cardiovascular | SFEBES2023

Mild autonomous cortisol secretion in patients with adrenal incidentalomas – how common and what is the prevalence of co-morbidities?

San Yap Pui , Paterson Rachel , Philip Sam , Graveling Alex , Abraham Prakash

The widespread use of cross-sectional imaging has led to increased detection of adrenal masses in 2% of general population and over 7% of those above age 70. Although majority are benign, it is important to exclude hormonally active or malignant lesions. Mild autonomous cortisol secretion (MACS) is the most common and found in 30-50% of patients with adrenal mass. We reviewed our adrenal incidentaloma database for patients who attended the nurse-led pathway for biochemistry in...

ea0094p135 | Thyroid | SFEBES2023

Using nurse led clinics (including telephone and virtual reviews) in NHS Grampian to improve patient satisfaction following a diagnosis of hyperthyroidism

Stirling Claire , Paterson Rachel , Middleton Morag , Murray Lynne , Milne Alison , Alex Graveling Dr , Prakash Abraham Dr

Using nurse led clinics (including telephone and virtual reviews) in NHS Grampian to improve patient satisfaction following a diagnosis of hyperthyroidism.Aims: To reduce waiting times for patients with hyperthyroidism, nurse led clinics were introduced. Telephone and virtual follow up reviews are offered after commencement of thyroid treatment (e.g. anti-thyroid medication or radioactive iodine (RAI)). Nurse-led thyroid clinics aim to i...

ea0077p20 | Adrenal and Cardiovascular | SFEBES2021

Adrenal Incidentaloma Pathway - A four-year experience at a teaching hospital

Rajan Roby , Chandy Shekinah Grace K M , Radhakrishnan Parvathy , Paterson Rachel , Aspinall Sebastian , Graveling Alex J , Philip Sam , Abraham Prakash

Background /Methods: Adrenal incidentalomas pose a significant burden to endocrinology services in assessing the clinical significance of these lesions. Following vetting of the incidentaloma referrals, the patients at our centre are initially seen in a nurse-led clinic for biochemical investigations and to ensure completion of radiology assessment using a structured proforma. This step facilitates efficient patient flow and quicker decision making. The clinical outcomes of th...

ea0050oc2.5 | Clinical Highlights | SFEBES2017

Additional value of 4D-CT in patients with primary hyperparathyroidism and negative conventional imaging; a reason to change primary imaging modality in patients over 60?

Alkemade Gonnie , Sifontes-Dubon Mildred , Bhatt Dhruti , Smith David , Duguid Rebecca , Straiton Jack , Dymot Jane , Graveling Alex , Abraham Prakash

Introduction: Minimally invasive surgical treatment of primary hyperparathyroidism (PHPT) requires optimal preoperative localisation imaging. Parathyroid four-dimensional CT (4D-CT) has been reported to provide greater sensitivity than MIBI-SPECT/CT in localizing parathyroid adenomas. We analysed the additional value of 4D-CT in our cohort of PHPT patients.Materials and methods: Patients who attended our parathyroid clinic between February 2016 and April...